Teva ready to divest operations to win regulatory nod for Mylan buy

(Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd said it could "promptly" divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller...